[go: up one dir, main page]

DK211989A - Molekylfaelde og anvendelse deraf - Google Patents

Molekylfaelde og anvendelse deraf Download PDF

Info

Publication number
DK211989A
DK211989A DK211989A DK211989A DK211989A DK 211989 A DK211989 A DK 211989A DK 211989 A DK211989 A DK 211989A DK 211989 A DK211989 A DK 211989A DK 211989 A DK211989 A DK 211989A
Authority
DK
Denmark
Prior art keywords
receptor
pct
decoyant
retains
sec
Prior art date
Application number
DK211989A
Other languages
English (en)
Other versions
DK175596B1 (da
DK211989D0 (da
Inventor
Jonathan M Gershoni
Original Assignee
Jonathan M Gershoni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonathan M Gershoni filed Critical Jonathan M Gershoni
Publication of DK211989D0 publication Critical patent/DK211989D0/da
Publication of DK211989A publication Critical patent/DK211989A/da
Application granted granted Critical
Publication of DK175596B1 publication Critical patent/DK175596B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Paper (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Polyamides (AREA)
DK198902119A 1987-08-30 1989-05-01 Molekylfælde og anvendelse deraf DK175596B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
IL8368787 1987-08-30
US8802991 1988-08-30
PCT/US1988/002991 WO1989001779A1 (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof

Publications (3)

Publication Number Publication Date
DK211989D0 DK211989D0 (da) 1989-05-01
DK211989A true DK211989A (da) 1989-06-28
DK175596B1 DK175596B1 (da) 2004-12-13

Family

ID=11058121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902119A DK175596B1 (da) 1987-08-30 1989-05-01 Molekylfælde og anvendelse deraf

Country Status (12)

Country Link
US (1) US5770572A (da)
EP (1) EP0329778B1 (da)
JP (1) JP2791074B2 (da)
AT (1) ATE123224T1 (da)
AU (1) AU2383988A (da)
CA (1) CA1336489C (da)
DE (1) DE3853910T2 (da)
DK (1) DK175596B1 (da)
FI (1) FI100169B (da)
IL (1) IL83687A (da)
NO (1) NO891787L (da)
WO (1) WO1989001779A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001940A1 (en) * 1987-09-04 1989-03-09 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
EP0318240A3 (en) * 1987-11-25 1990-08-16 AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE & INDUSTRY Peptide, adsorbent, method for production thereof, and method for use thereof
US5132402A (en) * 1987-11-25 1992-07-21 Agency Of Industrial Science And Technology Adsorbent, method for production thereof, and method for use thereof
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
ITRM20010563A1 (it) * 2001-09-14 2003-03-14 Univ Siena Peptidi antigenici multipli come antidoti nell'intossicazione da veleno di serpente.
US8535672B2 (en) * 2002-04-04 2013-09-17 Yissum Research Development Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
NZ537735A (en) * 2002-07-03 2006-08-31 Pericor Science Inc Compositions of hyaluronic acid and methods of use
JP4495776B1 (ja) 2009-07-30 2010-07-07 日本製薬株式会社 融合蛋白質
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
RS57397B8 (sr) 2011-06-10 2020-01-31 Univ Oregon Health & Science Cmv glikoproteini i rekombinantni vektori
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
WO2015153647A1 (en) * 2014-03-31 2015-10-08 Mice With Horns, Llc Method of preventing or reducing virus transmission in animals
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
JP3134874B2 (ja) * 1986-08-21 2001-02-13 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク Ｔ細胞表面タンパク質ｔ４をコードするｄｎａ並びにｔ４フラグメントのａｉｄｓ治療への使用
US5126433A (en) * 1986-08-21 1992-06-30 The Trustees Of Columbia University In The City Of New York Soluble forms of the t cell surface protein cd4

Also Published As

Publication number Publication date
NO891787D0 (no) 1989-04-28
US5770572A (en) 1998-06-23
FI100169B (fi) 1997-10-15
CA1336489C (en) 1995-08-01
DK175596B1 (da) 2004-12-13
IL83687A (en) 1995-03-30
FI892005A0 (fi) 1989-04-27
FI892005A (fi) 1989-04-27
ATE123224T1 (de) 1995-06-15
EP0329778A1 (en) 1989-08-30
AU2383988A (en) 1989-03-31
EP0329778B1 (en) 1995-05-31
EP0329778A4 (en) 1990-12-27
IL83687A0 (da) 1988-01-31
DE3853910T2 (de) 1995-10-12
JP2791074B2 (ja) 1998-08-27
DE3853910D1 (de) 1995-07-06
WO1989001779A1 (en) 1989-03-09
JPH02502538A (ja) 1990-08-16
DK211989D0 (da) 1989-05-01
NO891787L (no) 1989-06-06

Similar Documents

Publication Publication Date Title
DK211989A (da) Molekylfaelde og anvendelse deraf
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
BR0015506A (pt) Conjugados de interferon gama, métodos para sua preparação, composições farmacêuticas que compreendem ás moléculas e seu uso no tratamento de doenças
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
BR9812564A (pt) Amidas de ácido acilsulfamoilbenzóico, agentes protetores de plantas úteis contendo as mesmas e processos para a sua preparação
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
BR9408377A (pt) Composto composição farmacêutica processo para estimular a liberação de hormônio de crescimento da pituitária e uso do composto
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
SE8103594L (sv) N-(vinblastin-23-oyl)aminosyraderivat
ES2124702T3 (es) Usos terapeuticos de compuestos que se unen a actina.
ATE247985T1 (de) Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden
ES2117299T3 (es) Aparato para la inyeccion embrionaria temprana "in ovo".
DE3877547D1 (de) Basisches protein phospholipase a2 aus dem gift der schlangen aus der familie der elapiden, deren aminosaeuresequenz, derivate und fragmente dieses proteins, verfahren um es zu erhalten, therapeutische kompositionen und diagnosemittel, alle dieses protein enthaltend und/oder dessen derivate und/oder dessen fragmente.
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
ATE78162T1 (de) 5-ht3-rezeptor-antagonisten zur behandlung von husten und bronchokonstriktion.
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos
PT94625A (pt) Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem
ATE251631T1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
BR9808424A (pt) Composto, processos para a preparação do mesmo, para a preparação dos intermediários e para tratamento de um mamìfero, incluindo o ser humano, composição farmacêutica, e, uso de um composto.
BR8008818A (pt) Peptidos farmacologicamente ativos e medicamentos contendo os mesmos
ES2039402T3 (es) Empleo de peptidos n,n'-bis-l-aminoacido-l-cistina en preparados de aminoacidos para alimentacion oral y parenteral.
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
BR9403572A (pt) Composto, processo para sua preparação e formulação farmacêutica

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK